Pneumo Vaccine 20 Reaches SUS for Elderly People Aged 85 Years or Older
15 Articles
15 Articles
The 20-valent conjugated pneumococcal vaccine (pneumo 20) was first available in the Unified Health System (SUS) for people aged 85 years or older. Immunizer protects against pneumococcal disease and its severe forms, such as meningitis and pneumonia, which is one of the main causes of death of the elderly. The risk for this age group is in mechanisms of aging itself. The main factors are the natural aging process of the immune system and the hi…
This week, the Ministry of Health began offering the 20-valent conjugated pneumococcal vaccine, Pneumo 20, for people 85 years of age or older. Adopted for the first time in the country for this age group, the strategy seeks to reduce serious cases, complications, hospitalizations and deaths caused by pneumococcal disease, which includes conditions such as pneumonia and meningitis. According to the government, enlargement considers the greater v…
Expansion of the Pneumo20 vaccine aims to reduce hospitalizations and deaths in the elderly, who are more vulnerable to respiratory infections
Immunizing Pneum 20 broad protection against 20 serotypes of Streptococcus pneumoniae, identified as the most common cause of respiratory infections
Immunizing against 20 serotypes of Streptococcus pneumoniae bacteria is now available in SUS for people over 85 years of age
Coverage Details
Bias Distribution
- 100% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
